Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Determinants in APD selection.

Jimmy Wilson1, Allen R Nissenson

  • 1Division of Nephrology, Department of Medicine, UCLA School of Medicine, Los Angeles, California 90095, USA.

Seminars in Dialysis
|November 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breaking the Barriers to Innovation in Kidney Care: The Time is Now.

Clinical journal of the American Society of Nephrology : CJASN·2022
Same author

Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL.

Blood·2020
Same author

Redefining Medication Management in Dialysis: A Kidney Pharmacy Quality Pyramid.

Kidney medicine·2020
Same author

Advancing American Kidney Health: Perspective from DaVita, Inc.

Clinical journal of the American Society of Nephrology : CJASN·2019
Same author

Palliative dialysis: Addressing the need for alternative dialysis delivery modes.

Seminars in dialysis·2019
Same author

The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration.

Journal of the American Society of Nephrology : JASN·2019
Same journal

Intracardiac Vascular Access for Hemodialysis Despite Associated Ascending Aortic Aneurysm.

Seminars in dialysis·2026
Same journal

Measures of Equivalent Hemodialysis Urea Clearance and Their Proposed Utility for Monitoring Adequacy.

Seminars in dialysis·2026
Same journal

Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving Dialysis.

Seminars in dialysis·2026
Same journal

Severe Hematoma Following Initial Arteriovenous Fistula Puncture in a Hemodialysis Patient, Emphasizing Thoracic Outlet Syndrome: A Case Report.

Seminars in dialysis·2026
Same journal

Phosphate Kinetic Modeling in Patients Treated With Hemodialysis or Hemodiafiltration: A Prospective, Multicenter, Cross-Sectional Study.

Seminars in dialysis·2026
Same journal

Impact of Expanded Hemodialysis on Inflammation and Iron Metabolism in Chronic Hemodialysis Patients.

Seminars in dialysis·2026
See all related articles

Automated peritoneal dialysis (APD) is common in the US. Patient selection is key for APD success, considering factors like lifestyle, age, and kidney function for optimal outcomes in end-stage renal disease (ESRD).

Area of Science:

  • Nephrology
  • Renal Replacement Therapy

Background:

  • Automated peritoneal dialysis (APD) is the most common peritoneal dialysis method in the United States.
  • Optimal patient selection is crucial for APD success, but data on ideal candidates are limited.

Purpose of the Study:

  • To identify key factors for selecting patients who will most benefit from automated peritoneal dialysis (APD).

Main Methods:

  • Evaluation of patient preferences, lifestyle, age, solute transport characteristics, residual renal function (RRF), cost, dialysis adequacy, and potential complications.
  • Analysis of patient profiles to determine suitability for APD.

Main Results:

  • Ideal candidates for APD include those preferring nocturnal home dialysis, children, patients with high peritoneal transport, and those with significant residual renal function (RRF).

Related Experiment Videos

  • APD offers flexibility and can be successful in patients not meeting ideal criteria, especially within integrated care programs for end-stage renal disease (ESRD).

    • Conclusions:

    • Careful patient selection, considering a range of clinical and lifestyle factors, is essential for maximizing the benefits of automated peritoneal dialysis (APD).
    • APD is a versatile and effective treatment option for end-stage renal disease (ESRD), adaptable to diverse patient needs.